| Literature DB >> 34946578 |
Shi-Qing Cai1,2, Qiang Zhang2,3, Xin-Huai Zhao2,3,4, Jia Shi1.
Abstract
Flavonols possess several beneficial bioactivities in vitro and in vivo. In this study, two flavonols galangin and quercetin with or without heat treatment (100 °C for 15-30 min) were assessed for their anti-inflammatory activities in lipopolysaccharide (LPS)-stimulated rat intestinal epithelial (IEC-6) cells and whether the heat treatment caused activity changes. The flavonol dosages of 2.5-20 μmol/L had no cytotoxicity on the cells but could enhance cell viability (especially using 5 μmol/L flavonol dosage). The flavonols could decrease the production of prostaglandin E2 and three pro-inflammatory cytokines interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α, and simultaneously promote the production of two anti-inflammatory cytokines IL-10 and transforming growth factor-β. The Western-blot results verified that the flavonols could suppress the LPS-induced expression of TLR4 and phosphorylated IκBα and p65, while the molecular docking results also illustrated that the flavonols could bind with TLR4 and NF-κB to yield energy decreases of -(21.9-28.6) kJ/mol. Furthermore, an inhibitor BAY 11-7082 blocked the NF-κB signaling pathway by inhibiting the expression of phosphorylated IκBα/p65 and thus mediated the production of IL-6/IL-10 as the flavonols did, which confirmed the assessed anti-inflammatory effect of the flavonols. Consistently, galangin had higher anti-inflammatory activity than quercetin, while the heated flavonols (especially those with longer heat time) were less active than the unheated counterparts to exert these target anti-inflammatory effects. It is highlighted that the flavonols could antagonize the LPS-caused IEC-6 cells inflammation via suppressing TLR4/NF-κB activation, but heat treatment of the flavonols led to reduced anti-inflammatory efficacy.Entities:
Keywords: IEC-6 cells; TLR4/NF-κB signaling pathway; anti-inflammatory effect; flavonol; lipopolysaccharide; molecular docking
Mesh:
Substances:
Year: 2021 PMID: 34946578 PMCID: PMC8703769 DOI: 10.3390/molecules26247495
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of two natural flavonols galangin and quercetin.
Figure 2The measured viability values of the IEC-6 cells exposed to galangin (a) and quercetin (b) for treatment times of 6–24 h. Different lowercase letters (a–d) above the columns indicate that the mean values differ significantly (p < 0.05).
Detected levels (pg/mL) of three pro-inflammatory cytokines and PGE2 in IEC-6 cells with or without LPS, flavonols, and inhibitor (BAY 11-7082) treatments.
| Cell Group 1 | IL-1β | IL-6 | TNF-α | PGE2 |
|---|---|---|---|---|
| Control | 6.0 ± 0.3 f | 88.0 ± 2.7 f | 52.0 ± 4.6 e | 5.1 ± 0.5 d |
| Model | 40.5 ± 4.0 a | 205.7 ± 13.4 a | 206.3 ± 12.2 a | 19.3 ± 1.7 a |
| Galangin | 23.4 ± 2.1 e | 129.7 ± 10.6 d | 147.3 ± 4.9 d | 5.8 ± 0.6 d |
| Heated GA-15 | 29.2 ± 1.7 c,d | 133.1 ± 6.1 d | 156.3 ± 4.2 c,d | 6.9 ± 0.7 b,c,d |
| Heated GA-30 | 31.8 ± 1.2 b,c | 152.9 ± 6.8 b,c | 172.3 ± 6.1 b,c | 8.3 ± 0.3 b,c |
| Quercetin | 26.3 ± 3.3 d,e | 133.0 ± 7.6 d | 154.0 ± 10.5 d | 6.1 ± 1.1 c,d |
| Heated QE-15 | 32.6 ± 3.2 b,c | 139.4 ± 3.1 c,d | 163.0 ± 8.0 b,c,d | 7.2 ± 1.0 b,c,d |
| Heated QE-30 | 36.2 ± 1.8 a,b | 159.2 ± 8.1 b | 177. 7 ± 7.0 b | 8.7 ± 0.2 b |
| Inhibitor | Not assessed | 102.3 ± 7.0 e | Not assessed | Not assessed |
1 GA, galangin; QE, quercetin; the numbers following these flavonol names indicate the heat time (min) used in the sample preparation. Different lowercase letters (a–f) after the data as the superscripts in the same column indicate that the mean values of ANOVA using Duncan’s multiple comparison test differ significantly (p < 0.05).
Detected levels (pg/mL) of two anti-inflammatory cytokines in IEC-6 cells with or without LPS, flavonols, and inhibitor (BAY 11-7082) treatments.
| Cell Group 1 | IL-10 | TGF-β |
|---|---|---|
| Control | 26.1 ± 1.4 c,d | 36.8 ± 1.7 b,c,d |
| Model | 6.5 ± 1.3 f | 29.4 ± 1.6 f |
| Galangin | 35.9 ± 1.4 a | 45.6 ± 1.1 a |
| Heated GA-15 | 32.8 ± 1.4 b | 41.0 ± 2.5 a,b |
| Heated GA-30 | 28.2 ± 1.2 c | 34.1 ± 3.1 d,e |
| Quercetin | 27.4 ± 1.2 c | 40.5 ± 3.5 b,c |
| Heated QE-15 | 24.2 ± 0.7 d | 36.1 ± 1.4 c,d,e |
| Heated QE-30 | 17.4 ± 2.2e | 32.0 ± 2.2 e,f |
| Inhibitor | 25.5 ± 1.0 c,d | Not assessed |
1 GA, galangin; QE, quercetin; the numbers following these flavonol names indicate the heat time (min) used in the sample preparation. Different lowercase letters (a–f) after the data as the superscripts in the same column indicate that the mean values of ANOVA using Duncan’s multiple comparison test differ significantly (p < 0.05).
Figure 3The anti-inflammatory effect of galangin and quercetin on the IEC-6 cells with LPS-caused inflammation.
Figure 4In silico analysis 3D results of the possible covalent interactions between the target TLR4/NF-κB proteins and the target molecules including galangin (a,c), quercetin (b,d), and the inhibitor BAY 11-7082 (e).
Analysis results for the affinity of two flavonols or inhibitor (BAY 11-7082) to TLR4 or NF-κB.
| Binding Model | Binding Energy | Amino Acid Residues Involved in the Interaction |
|---|---|---|
| Galangin-TLR4 | −23.4 | Leu-434, Lys-435, Gln-436, Met-437, Ser-438 *, Glu-439 *, His-458, Thr-459, Arg-460 * |
| Quercetin-TLR4 | −21.9 | Leu-198, His-199*, Met-201, Pro-202, Leu-204, Glu-225, Ile-226, Arg-227* |
| Galangin-NF-κB | −28.6 | Val-219, Gln-220 *, Lys-221, Glu-222, Arg-246, Gln-247, Pro-281 *, Glu-282, Ser-283 *, Glu-286, Glu-287, Ser-288 |
| Quercetin-NF-κB | −28.2 | Lys-221 *, Glu-222, Ile-224, Glu-225, Gly-237, Ser-238, Ser-240, Phe-239 *, Gln-241, Gly-259, Arg-260 *, Pro-261 |
| Inhibitor-NF-κB | −29.0 | Lys-221, Val-244, His-245 *, Tyr251, Arg-246 *, Gln-249 *, Pro-281, Glu-287, Ser-288, Tyr-289, Asp-290 |
The residues with asterisks indicate H-bonding with these residues.
Figure 5The 2D results for the chemical groups involved in the interactions between TLR4/NF-κB proteins and the target molecules including galangin (a,c), quercetin (b, d), and the inhibitor BAY 11-7082 (e).